相关实验视频
Updated: May 6, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
低分化与常规分化相比,在中期和高风险局部前列腺癌中,外部光束放射治疗具有很高的风险
Eileen Samuel1, Saliha Zaman2, Muhammad Abu Bakar3
1Department of Clinical and Radiation Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.
Discover oncology
|February 2, 2024
概括
与传统的外部光束放射疗法相比,低分离放射疗法为前列腺癌患者提供了改善的无病生存率. 虽然它可能会增加直肠炎和囊炎的风险,但整体存活率仍然相似,这使得它成为一种可行的治疗选择.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
背景情况:
- 前列腺癌是一个日益严重的全球健康问题,排名第二最常见的恶性瘤在男性.
- 中期和高风险前列腺癌的治疗包括手术,激素治疗和放射治疗.
- 低分离放射治疗正在获得引力,因为人们对前列腺癌放射生物学和后勤优势的理解得到了改善.
研究的目的:
- 为了比较 hypofractionated 与常规外部束辐射疗法的有效性和毒性,用于局部前列腺癌.
- 评估在Shaukat Khanum纪念医院和研究中心接受治疗的中期和高风险前列腺癌患者的结果.
主要方法:
- 这是一项对114名前列腺腺癌患者的回顾性研究,这些患者于2013年1月至2018年12月期间接受治疗.
- 患者接受了激进的放射治疗,并按照指示进行激素治疗.
- 从电子医院记录中收集的数据,并使用SPSS版本23进行分析.
主要成果:
- 低分离放射治疗显示,在5年无病存活率上有统计学显著的改善 (100%对比75%,p=0.04).
- 在低分离组中观察到较高的2级直肠炎 (14%vs. 5%) 和囊炎 (8%vs. 2.9%),尽管整体毒性在临床上是微不足道的 (p=0.11).
- 在低分离 (100%) 和常规 (90%) 放射治疗组 (p=0.3) 之间,5年总生存率是可比的.
结论:
- 低分离放射治疗显示,中期和高风险前列腺癌的无病生存率优越.
- 带有低分离性直肠炎和囊炎的风险增加是改善疾病控制的权衡.
- 在低分离和常规放射治疗方案之间,总体存活率没有显著差异.
相关概念视频
Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K

